In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

The vaccine — using messenger RNA (mRNA) technology similar to that found in some Covid vaccines — activated tumour-targeting immune cells that persisted for nearly four years after surgery in ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...